Prevention and control measures for hepatitis B
Guidance on prevention and control measures for hepatitis B
Hepatitis B - Annual Epidemiological Report 2016 [2014 data]
In 2014, 30 EU/EEA Member States reported 22 442 cases of hepatitis B virus (HBV) infection, a crude rate of 4.2 cases per 100 000 population.
Hepatitis B - Annual Epidemiological Report for 2015
In 2015, 30 EU/EEA Member States reported 24 573 cases of hepatitis B virus (HBV) infection, a crude rate of 4.7 cases per 100 000 population.
EU/EEA capacity for the surveillance of hepatitis B and C using molecular methods
In order to explore whether the current capacity for EU/EEA-wide molecular characterisation for surveillance of HBV and HCV is sufficient to be feasible and what gaps need to be addressed, a survey of EU/EEA Member States was conducted to assess their laboratory capacity and needs in relation to the molecular characterisation of hepatitis B and C.
Country mission Latvia: HIV, STI and hepatitis B and C
This report describes a country mission undertaken by ECDC in 2011 to Latvia, to address issues relating to HIV, STI and hepatitis B and C identified by the Latvian government.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA: Executive summary
Hepatitis B and C surveillance in Europe 2012
This is the second report on the enhanced surveillance of hepatitis B and C viral infections. It describes basic epidemiological features and trends of both diseases across countries in the EU/EEA for 2012.
HIV and hepatitis B and C in Latvia
At the request of the Ministry of Health in Riga, a team of experts from ECDC and the European Monitoring Centre for Drugs and Drug Addiction paid a technical visit to Latvia on 2–4 September 2014.